ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

A reactive oxygen species-related signature to predict prognosis and aid immunotherapy in clear cell renal cell carcinoma

Liu, Hongxiang; Luo, Yong; Zhao, Shankun; Tan, Jing; Chen, Minjian; Liu, Xihai; Ye, Jianheng; Cai, Shanghua; Deng, Yulin; Li, Jinchuang; He, Huichan; Zhang, Xin*; Zhong, Weide*广州医学院; 南方医科大学; 1
Frontiers in Oncology2023-7-11DOI: 10.3389/fonc.2023.1202151
1被引12阅读
引用收藏
分享

摘要

BackgroundClear cell renal cell carcinoma (ccRCC) is a malignant disease containing tumor-infiltrating lymphocytes. Reactive oxygen species (ROS) are present in the tumor microenvironment and are strongly associated with cancer development. Nevertheless, the role of ROS-related genes in ccRCC remains unclear. MethodsWe describe the expression patterns of ROS-related genes in ccRCC from The Cancer Genome Atlas and their alterations in genetics and transcription. An ROS-related gene signature was constructed and verified in three datasets and immunohistochemical staining (IHC) analysis. The immune characteristics of the two risk groups divided by the signature were clarified. The sensitivity to immunotherapy and targeted therapy was investigated. ResultsOur signature was constructed on the basis of glutamate-cysteine ligase modifier subunit (GCLM), interaction protein for cytohesin exchange factors 1 (ICEF1), methionine sulfoxide reductase A (MsrA), and strawberry notch homolog 2 (SBNO2) genes. More importantly, protein expression levels of GCLM, MsrA, and SBNO2 were detected by IHC in our own ccRCC samples. The high-risk group of patients with ccRCC suffered lower overall survival rates. As an independent predictor of prognosis, our signature exhibited a strong association with clinicopathological features. An accurate nomogram for improving the clinical applicability of our signature was constructed. Gene Ontology and Kyoto Encyclopedia of Genes and Genomes analyses showed that the signature was closely related to immune response, immune activation, and immune pathways. The comprehensive results revealed that the high-risk group was associated with high infiltration of regulatory T cells and CD8+ T cells and more benefited from targeted therapy. In addition, immunotherapy had better therapeutic effects in the high-risk group. ConclusionOur signature paved the way for assessing prognosis and developing more effective strategies of immunotherapy and targeted therapy in ccRCC.

学科与关键词

关键词
clear cell renal cell carcinomareactive oxygen speciesprognosisimmune infiltratesimmunotherapy
相关
加载中…
  • A pyroptosis-associated signature plays a role in prognosis prediction in clear cell renal cell carcinoma
    Li, Zhiyuan; Xia, Zhinan; Yu, Yipeng; Cai, Licheng; Jian, Wengang; Wang, Tengda; Xue, Wei; Wang, Xingyuan; Wang, Bowen; Zhang, Peng; Yao, Wenhao; Zhang, Cheng*; Wang, Chunyang*BMC Medical Genomics, 2022, 15(1): 204.被引 3
  • A novel 7-chemokine-genes predictive signature for prognosis and therapeutic response in renal clear cell carcinoma
    Lin, Ming-Jie; Tang, Xiu-Xiao; Yao, Gao-Sheng; Tan, Zhi-Ping; Dai, Lei; Wang, Ying-Han; Zhu, Jiang-Quan; Xu, Quan-Hui; Mumin, Mukhtar Adan; Liang, Hui; Wang, Zhu; Deng, Qiong; Luo, Jun-Hang*; Wei, Jin-Huan*; Cao, Jia-Zheng*Frontiers in Pharmacology, 2023, 14: 1120562.
  • A Predictive Model Based on Pyroptosis-Related Gene Features Can Effectively Predict Clear Cell Renal Cell Carcinoma Prognosis and May Be an Underlying Target for Immunotherapy
    Wang, Yufu; Liu, Jinhui; Zhang, Lishuo; Li, Yifei*DISEASE MARKERS, 2022, 2022: 6402599.
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Oncology
发表日期
2023-07-11
卷期
第 13 卷
页码
1202151
DOI
10.3389/fonc.2023.1202151
成果收录
SCIE
资助标注
National Natural Science Foundation of China [82072813]; Science and Technology Development Fund (FDCT) of Macau SAR [0031/2021/A, 0090/2022/A]; Second People's Hospital of Foshan Fund Project [2022B05]

作者

  • L

    Liu, Hongxiang (第一作者)

  • L

    Luo, Yong

    2 · southern med univ

查看全部 13 位作者收起作者
  • Z

    Zhao, Shankun

    taizhou univ

  • T

    Tan, Jing

  • C

    Chen, Minjian

  • L

    Liu, Xihai

  • Y

    Ye, Jianheng

    1

  • C

    Cai, Shanghua

    guangzhou med univ · 1

  • D

    Deng, Yulin

    1 · guangzhou med univ

  • L

    Li, Jinchuang

    1

  • H

    He, Huichan

    guangzhou med univ

  • Z

    Zhang, Xin (通讯)

    2 · southern med univ

  • Z

    Zhong, Weide (通讯)

    1 · guangzhou med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417